Enanta Pharmaceuticals
ENTA
ENTA
147 hedge funds and large institutions have $1.1B invested in Enanta Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 42 increasing their positions, 71 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
3% less funds holding
Funds holding: 151 → 147 (-4)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
41% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 71
Holders
147
Holding in Top 10
3
Calls
$2.92M
Puts
$53K
Top Buyers
| 1 | +$53.2M | |
| 2 | +$17.6M | |
| 3 | +$10.4M | |
| 4 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$7.89M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4.48M |
Top Sellers
| 1 | -$9.94M | |
| 2 | -$9.32M | |
| 3 | -$7.28M | |
| 4 |
Millennium Management
New York
|
-$7.12M |
| 5 |
BlackRock
New York
|
-$4.37M |